PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.27%
Revenue growth above 1.5x 3391.T's 3.01%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
9.27%
Gross profit growth above 1.5x 3391.T's 4.01%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
16.77%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
29.33%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
31.60%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
31.60%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
31.60%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.86%
10Y revenue/share CAGR under 50% of 3391.T's 211.20%. Michael Burry would suspect a lasting competitive disadvantage.
81.50%
5Y revenue/share CAGR similar to 3391.T's 90.55%. Walter Schloss might see both companies benefiting from the same mid-term trends.
44.91%
3Y revenue/share CAGR at 75-90% of 3391.T's 49.98%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
149.69%
Below 50% of 3391.T's 476.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
103.51%
5Y net income/share CAGR above 1.5x 3391.T's 49.87%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
27.68%
Positive short-term CAGR while 3391.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
198.41%
10Y equity/share CAGR in line with 3391.T's 214.85%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
123.92%
5Y equity/share CAGR above 1.5x 3391.T's 74.47%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
56.55%
3Y equity/share CAGR above 1.5x 3391.T's 35.33%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
160.87%
Below 50% of 3391.T's 121057.86%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
84.62%
5Y dividend/share CAGR 1.25-1.5x 3391.T's 76.30%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
33.33%
3Y dividend/share CAGR above 1.5x 3391.T's 8.14%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-48.82%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
7.60%
Inventory growth well above 3391.T's 0.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.64%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.21%
1.25-1.5x 3391.T's 4.13%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
63.09%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-44.38%
We cut SG&A while 3391.T invests at 14.13%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.